Drug Shortage Alert: Electrolyte Medication Shortages
Back to course
Pdf Summary
Asset Subtitle
Pharmacology, Crisis Management, 2022, 0:15:18
Asset Caption
"Updated September 2022

Lack of availability of any IV electrolyte can have serious consequences. As such, an interdisciplinary team should systematically analyze institutional usage patterns and automatic electrolyte replacement protocols and policies. Depending on current availability, routine usage of these IV electrolytes should be evaluated, and restrictive criteria (e.g., based on indication or severity of laboratory findings) may need to be implemented to conserve existing supply for critical patients and indications. This alert is for the following electrolytes: Concentrated calcium, Concentrated magnesium, Concentrated phosphate, Concentrated potassium, and Concentrated sodium. The recommendations provided within this document are based on current evidence, including a review of available literature by the SCCM Drug Shortages and Medication Safety Committee and the need for conservation during this shortage.

Recommendations and information provided in this Drug Shortage Alert are compiled by experts in the field. Practitioners are advised to consult with their institution’s staff to ensure that response to any drug shortage is in line with internal policies and procedures.
"
Meta Tag
Content Type Article
Knowledge Area Pharmacology
Knowledge Area Crisis Management
Knowledge Level Foundational
Knowledge Level Intermediate
Knowledge Level Advanced
Membership Level Nonmember
Membership Level Associate
Membership Level Professional
Membership Level Select
Tag Electrolytes
Tag Resource Allocation
Year 2022
Keywords
drug shortage
IV electrolytes
calcium
magnesium
phosphate
potassium
sodium
patient safety
interdisciplinary teams
pharmacotherapeutic considerations